Updated on 11 October 2026
Frequentia: Digital Neurotherapy for Brain Longevity
CEO-Co-founder at Aequilibria Health
Rome, Italy
About
About
Frequentia brings laboratory-grade neurotechnology directly to consumers and healthcare providers through an accessible mobile app. Built on cutting-edge research into Gamma brainwave entrainment (40 Hz), Frequentia translates proven neuroscientific principles into an effortless daily routine.
Core concept
By synchronizing precise photic stimulation with engineered auditory soundscapes, Frequentia non-invasively stimulates 40 Hz Gamma oscillations in the brain. Gamma waves are the brain’s fastest natural rhythms, playing a pivotal role in executive function, working memory, sensory processing, and mood regulation.
Key Benefits
-
Activates Natural Brain Cleanup: Rhythmic 40 Hz stimulation promotes the brain's natural cellular clearing processes to support long-term cognitive health.
-
Supports Focus & Memory: Enhances attention, mental clarity, and executive performance during daily tasks.
-
Protects Cognitive Vitality: Promotes neuroprotective mechanisms and structural preservation to slow down age-related cognitive decline.
-
Effortless Home Therapy: Converts any smartphone into a personalized neurotherapy tool requiring just 30 to 60 minutes a day with headphones.
Looking for
- Buyer
- Re-Seller/Wholesaler
- License partner
- Demonstration / Pilot projects
- Investment/Finance
Similar opportunities
Project cooperation
Collaboration in research projects
- Market Access
- Strategic Partnership
- Technological contribution
Emanuela Russo
CEO-Co-founder at Aequilibria Health
Rome, Italy
Partnership
- Research
- Business
- Joint development
- Testing of technology
Emanuela Russo
CEO-Co-founder at Aequilibria Health
Rome, Italy
Investment
Investment opportunities in brain health and longevity
- Seed funding | Get business started
Emanuela Russo
CEO-Co-founder at Aequilibria Health
Rome, Italy